| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/26/2001 | EP1135153A1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 09/26/2001 | EP1135151A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 09/26/2001 | EP1135135A1 Chk1 kinase inhibitors |
| 09/26/2001 | EP1135131A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 09/26/2001 | EP1135126A2 Myt1 kinase inhibitors |
| 09/26/2001 | EP1135123A1 Use of isatin derivatives as ion channel activating agents |
| 09/26/2001 | EP1135120A2 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 09/26/2001 | EP1135105A2 Method for administering agents to the central nervous system |
| 09/26/2001 | EP0909271B1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 09/26/2001 | EP0839026B1 Polyether block copolymer micellar compositions for targeting biological agents |
| 09/26/2001 | EP0804581B1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
| 09/26/2001 | EP0773943B1 Compounds useful as antiproliferative agents and garft inhibitors |
| 09/26/2001 | EP0767796B1 Chemotactic protein |
| 09/26/2001 | EP0528991B1 Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof. |
| 09/26/2001 | CN1314948A Targeted adenovirus vectors for delivery of heterologous genes |
| 09/26/2001 | CN1314943A Method for producing plants with increased flavonoid and phenolic compound content |
| 09/26/2001 | CN1314939A Inhibition of graft versus host disease |
| 09/26/2001 | CN1314917A Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinase |
| 09/26/2001 | CN1314914A Proteins for cancer cell specific induction of apoptosis and method for isolation thereof |
| 09/26/2001 | CN1314904A Alkynyl-substituted quinoline-2-one derivatives useful as anticancer agents |
| 09/26/2001 | CN1314900A Particle-formijng compositions containing fused pyrrolocarbazoles |
| 09/26/2001 | CN1314890A Cyanoguanidines as cell proliferation inhibitors |
| 09/26/2001 | CN1314882A NAALADase inhibitors useful as pharmaceutical compound and compositions |
| 09/26/2001 | CN1314816A Low molecular weight compositions of shark cartilage, processes for their preparation and therapeutic uses thereof |
| 09/26/2001 | CN1314409A New polypeptide-human ataxia-telangiectasia mutatioin protein 11 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314389A New polypeptide-human excitatory amino acid transport protein 12 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314388A New polypeptide-human prostatic specific membrane anti-body protein 12 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314387A New polypeptide-human chlorine ion path protein 10 and polynucleotide for coding this polypeptide |
| 09/26/2001 | CN1314385A New polypeptide-prostatic specific membrane antigen 9 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314379A New polypeptide-human microtubulin folding facto4 C 13 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314370A New polypeptide-human peroxisome assembly factor-10 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314365A New polypeptide-human helix-loop helix protein 17 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314359A New polypeptide-tumor inhibiting factor 63 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314351A Process for synthesizing quinazolone and quinazolone compound with anti-cancer function |
| 09/26/2001 | CN1314347A Six kinds of isoquinoline alkaloid |
| 09/26/2001 | CN1071760C N-terminally chemically modified protein composition and methods |
| 09/26/2001 | CN1071759C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and use thereof |
| 09/26/2001 | CN1071743C Sulfuryl or sulfufiny/benzoyl guanidine derivative |
| 09/26/2001 | CN1071579C Process for preparing anti-body conjugates for treamtent of tumor disease |
| 09/26/2001 | CN1071577C Medicine for curing cancer and preparing method |
| 09/25/2001 | US6294674 Dibenzofuran sulfonamide matrix metalloproteinase inhibitors |
| 09/25/2001 | US6294650 A peptide nucleic acid sequence of six to twenty-five nucleobases which hybridizes to an rna; therapy and detection of cancer |
| 09/25/2001 | US6294649 A cytotoxic peptide; therapy for breast cancer, brain tumor, kidney tumors; antitumor/antiproliferative/anticarcinogenic agents |
| 09/25/2001 | US6294562 Salts of ethyl 3-(2-(4-(4-amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenylpropionate |
| 09/25/2001 | US6294561 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/25/2001 | US6294560 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
| 09/25/2001 | US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/25/2001 | US6294552 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 09/25/2001 | US6294546 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 09/25/2001 | US6294531 Calcilytic compounds |
| 09/25/2001 | US6294525 Reverse-turn mimetics and methods relating thereto |
| 09/25/2001 | US6294378 Method and reagents for genetic immunization |
| 09/25/2001 | US6294377 Adenoviral vectors of canine origin |
| 09/25/2001 | US6294350 Methods for treating fibroproliferative diseases |
| 09/25/2001 | US6294348 Detection of moduators of signal transduction; incubate sample with modulator and monitor sample for adjustment in signal transduction |
| 09/25/2001 | US6294171 Methods for treating disease states comprising administration of low levels of antibodies |
| 09/25/2001 | CA2214601C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/25/2001 | CA2214051C Beta-lactams useful in preparation of taxols |
| 09/24/2001 | WO2003006652A2 Inhibition of specific histone deacetylase isoforms |
| 09/24/2001 | CA2408385A1 Inhibition of specific histone deacetylase isoforms |
| 09/20/2001 | WO2001069240A1 Assay for agents that induce chemokinesis |
| 09/20/2001 | WO2001068912A2 Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
| 09/20/2001 | WO2001068911A2 Diagnosis of diseases associated with the cell cycle |
| 09/20/2001 | WO2001068888A2 Production of chimeric capsid vectors |
| 09/20/2001 | WO2001068880A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 09/20/2001 | WO2001068866A2 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use |
| 09/20/2001 | WO2001068860A1 Antibodies to human cd154 |
| 09/20/2001 | WO2001068851A2 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | WO2001068837A2 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 09/20/2001 | WO2001068825A1 Human nim1 kinase |
| 09/20/2001 | WO2001068802A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/20/2001 | WO2001068720A1 Embolic compositions |
| 09/20/2001 | WO2001068708A2 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | WO2001068707A1 Human hepatocyte growth factor activator inhibitor homologue |
| 09/20/2001 | WO2001068704A2 G-protein coupled receptors |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068690A1 A new polypeptide-human zinc finger protein 15 and the polynucleotide encoding it |
| 09/20/2001 | WO2001068686A1 A novel polypeptide-human mannosephosphate isomerase 16 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068684A1 A novel polypeptide-human protocadherins 14 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068682A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | WO2001068679A2 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | WO2001068677A2 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 09/20/2001 | WO2001068676A2 Lhrh-antagonists, production and use thereof as medicament |
| 09/20/2001 | WO2001068663A1 Nucleoside compounds and uses thereof |
| 09/20/2001 | WO2001068654A2 Tubulin binding ligands and corresponding prodrug constructs |
| 09/20/2001 | WO2001068653A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents |
| 09/20/2001 | WO2001068643A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | WO2001068634A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 09/20/2001 | WO2001068633A1 2-phenylpyran-4-one derivatives |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068618A1 Bifunctional chelating agent |
| 09/20/2001 | WO2001068607A1 Amide compounds and use thereof |
| 09/20/2001 | WO2001068597A1 N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them |
| 09/20/2001 | WO2001068587A1 Novel crystal of stilbene derivative and process for producing the same |
| 09/20/2001 | WO2001068570A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068569A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068148A1 Systemic gene delivery vehicles for the treatment of tumors |
| 09/20/2001 | WO2001068147A2 Synthetic oligonucleotides as inducers of erythroid differentiation |
| 09/20/2001 | WO2001068146A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 09/20/2001 | WO2001068145A2 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |